Nanoparticle Delivery of Cancer Drugs

Lipoplatin™ Monotherapy: A Phase II Trial of Second-Line Treatment of Metastatic Non-Small-Cell Lung Cancer

(2014) A. Ravaioli et al.   JOURNAL OF CHEMOTHERAPY

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

(2011) R Plummer et al.   BRITISH JOURNAL OF CANCER

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

(2011) Eric J. Feldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101

(2011) Sonke Svenson et al.   JOURNAL OF CONTROLLED RELEASE

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

(2011) Shanta Dhar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phase I Study of NK012, a Novel SN-38-Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors

(2010) T. Hamaguchi et al.   CLINICAL CANCER RESEARCH

Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation

(2010) Maja J.A. de Jonge et al.   EUROPEAN JOURNAL OF CANCER

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

(2010) Juan W. Valle et al.   INVESTIGATIONAL NEW DRUGS

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

(2010) Mark E. Davis et al.   NATURE

Targeting nanoparticles to cancer

(2010) M. Wang et al.   PHARMACOLOGICAL RESEARCH

Nanoparticle Trojan Horses Gallop From the Lab Into the Clinic

(2010) R. F. Service   SCIENCE

Engineering Nanocomposite Materials for Cancer Therapy

(2010) Caterina Minelli et al.   Small

Preclinical and clinical studies of anticancer agent-incorporating polymer micelles

(2009) Yasuhiro Matsumura et al.   CANCER SCIENCE

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors

(2009) G. Batist et al.   CLINICAL CANCER RESEARCH

Nanomedicine based approaches for the delivery of siRNA in cancer

(2009) B. Ozpolat et al.   JOURNAL OF INTERNAL MEDICINE

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

(2009) N. Mylonakis et al.   LUNG CANCER

Mediating Tumor Targeting Efficiency of Nanoparticles Through Design

(2009) Steven D. Perrault et al.   NANO LETTERS

Protein nanoparticles as drug carriers in clinical medicine

(2008) Michael J. Hawkins et al.   ADVANCED DRUG DELIVERY REVIEWS

Biofunctionalized targeted nanoparticles for therapeutic applications

(2008) Andrew Z Wang et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments

(2008) Martin Benesch et al.   EXPERT OPINION ON PHARMACOTHERAPY

Role of Particle Size in Phagocytosis of Polymeric Microspheres

(2008) Julie A. Champion et al.   PHARMACEUTICAL RESEARCH

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers

(2008) F. Gu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The effect of particle design on cellular internalization pathways

(2008) S. E. A. Gratton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent Developments in Taxane Drug Delivery

(2008) Ahmad Safavy   Current Drug Delivery